health π¬ New ADC Shows Promise for Pediatric Sarcoma
An antibody-drug conjugate (ADC) is showing efficacy against Ewing sarcoma, an aggressive bone cancer in kids. This research focused on LINGO1-targeting ADCs in pre-clinical mouse xenograft models. The study demonstrated that the ADC successfully suppressed tumor growth without causing toxic side effects in mice. Researchers believe LINGO1's selective expression on tumor cells could limit ADC side effects significantly. Next steps involve testing these treatments in immunocompetent mouse models and patient cohorts. π¬